本文選題：跨國制藥企業(yè) + 發(fā)展戰(zhàn)略�。� 參考：《東華大學》2014年碩士論文

【摘要】：制藥產(chǎn)業(yè)一直對人類而言作為最核心的產(chǎn)業(yè)之一,其價值與意義為不得過高估計。隨著中國對外國開放,政府政策對跨國投資者而言越來越有優(yōu)勢,跨國制藥企業(yè)開始注意此潛力與機遇巨大的市場。跨國制藥企業(yè)在中國發(fā)展可以跟蹤到20世紀80年代。當時其開始冉冉地進入中國,熟悉市場,建立在華存在。該項研究探索跨國制藥企業(yè)在華現(xiàn)狀與面臨的問題。目前,30多年發(fā)展歷程以后,跨國制藥企業(yè)獲得中國藥品市場的1／3,把中國作為戰(zhàn)略性擴展的重點。因此,跨國制藥企業(yè)獲得許多中國提供給的優(yōu)勢,包括大的人才庫,稅收激勵,成本降低,以及經(jīng)受幾個問題與挑戰(zhàn),例如,國家價格控制策略、復雜的分配系統(tǒng)與假冒的藥品。研究集中跨國制藥企業(yè)在華現(xiàn)狀的詳細信息,并比較一些核心數(shù)據(jù)來表示跨國制藥企業(yè)在中國發(fā)展的績效。另外,研究概要并詳細的議論這些企業(yè)面臨的問題與它們導致的影響。 該項研究的重點為跨國制藥企業(yè)在華發(fā)展歷程當中的戰(zhàn)略調(diào)整,最核心的問題為跨國制藥企業(yè)在華發(fā)展過程中選擇怎樣的方法,如何保持不斷的上升,中國的對這些企業(yè)的角色如何變成。研究過程當中全球10大制藥企業(yè)作為樣本。研究結(jié)果提議,跨國制藥企業(yè)在華發(fā)展分為三個主要階段,初期(1979年——1992年),中期(1992年一2002年)與后期(2002年至今)。研究的目的之一為發(fā)現(xiàn)每個階段當中企業(yè)發(fā)展的特征,歸納跨國制藥企業(yè)在華發(fā)展步驟與、精選的方式。除此之外,研究提供給數(shù)據(jù)來顯示跨國制藥企業(yè)不僅一直擴展中國市場、重視中國若重要的生產(chǎn)與研發(fā)基地,而且證明作為樣本的全球10大制藥企業(yè)在華進行的戰(zhàn)略試有效的。 此論文得出一些戰(zhàn)略性特征、步驟與趨勢,希望助于制藥產(chǎn)業(yè)的企業(yè)從全球十大企業(yè)的建立獲得有效的建議與理念。
[Abstract]:Pharmaceutical industry has always been one of the core industries for human beings, its value and significance must not be overestimated. As China opens up to foreign countries and government policies become more and more advantageous for multinational investors, multinational pharmaceutical companies are beginning to pay attention to this potential and huge market opportunities. The development of multinational pharmaceutical enterprises in China can be traced to the 1980 s. At that time, it began to slowly enter China, familiar with the market and establish a presence in China. This study explores the current situation and problems faced by multinational pharmaceutical enterprises in China. After more than 30 years of development, multinational pharmaceutical enterprises have gained a third of China's drug market, and regard China as the focus of strategic expansion. As a result, multinational pharmaceutical companies gain many of the advantages that China offers, including a large pool of talent, tax incentives, lower costs, and several problems and challenges, such as national price control strategies. Complex distribution systems with counterfeit drugs. This paper focuses on the detailed information of multinational pharmaceutical enterprises in China and compares some core data to show the performance of multinational pharmaceutical enterprises in China. In addition, the study outlines and discusses in detail the problems faced by these companies and their implications. The focus of this study is on the strategic adjustment of multinational pharmaceutical enterprises in the development process in China. The most important question is what methods to choose and how to keep increasing in the process of development of multinational pharmaceutical enterprises in China. How China's role towards these companies has become. During the research process, the world's 10 largest pharmaceutical companies as a sample. The results suggest that the development of multinational pharmaceutical enterprises in China can be divided into three main stages: the initial stage (1979-1992), the middle stage (1992-2002) and the later period (2002-present). One of the purposes of the study is to find out the characteristics of enterprise development in each stage, and to sum up the development steps and methods of multinational pharmaceutical enterprises in China. In addition, the study provides data to show that multinational pharmaceutical companies not only have been expanding the Chinese market, attach importance to China's important production and research and development base, but also prove that the strategic trial conducted by the 10 largest pharmaceutical companies in the world as a sample is effective in China. This paper obtains some strategic features, steps and trends, hoping to help pharmaceutical industry enterprises to obtain effective suggestions and ideas from the establishment of ten enterprises in the world.
【學位授予單位】：東華大學
【學位級別】：碩士
【學位授予年份】：2014
【分類號】：F272;F416.72

【參考文獻】

相關(guān)期刊論文 前6條

1 康敬琦;核心競爭力與跨國公司在華發(fā)展戰(zhàn)略之研究[J];商業(yè)研究;2003年08期

2 王紹西;跨國公司發(fā)展戰(zhàn)略新趨勢[J];國際貿(mào)易;1995年08期

3 王志樂;;跨國公司在中國的發(fā)展走勢[J];國際融資;2009年04期

4 邱立成,于李娜;跨國公司進入中國市場模式及影響因素分析[J];南開經(jīng)濟研究;2003年04期

5 馮波;論跨國公司的中國市場戰(zhàn)略[J];世界經(jīng)濟與政治論壇;2005年03期

6 彭金榮,徐忠蘭;跨國公司發(fā)展戰(zhàn)略特征與我國開放戰(zhàn)略[J];天津大學學報(社會科學版);2001年02期

，

本文編號：1955704